Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: heart disease

Beyond the Clinic: Lessons Learned from a Rheumatologist with RA

Linda Childers  |  November 7, 2023

A pediatric rheumatologist diagnosed with RA following the birth of her first child talks about integrative care & offers tips for helping patients reduce the symptom burden. 

Filed under:Patient PerspectiveRheumatoid Arthritis Tagged with:RA Resource CenterRheumatoid Arthritis (RA)

Criteria, Guidelines & Medications: Updates in the World of Vasculitis

Jason Liebowitz, MD, FACR  |  November 1, 2023

The 19th Annual Johns Hopkins Advances in the Diagnosis and Treatment of Rheumatic Diseases Symposium session titled, Updates on Vasculitis provided an overview of the latest information on vasculitis diagnosis and treatment.

Filed under:ConditionsMeeting ReportsVasculitis Tagged with:ANCA-Associated VasculitisEGPAGPAmicroscopic polyangiitis (MPA)

Design Thinking & The Rheumatologist

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  October 11, 2023

If you’ve been a long-time reader  of The Rheumatologist, you may have noticed that things look just a little different in this issue. The logo has changed, the font appears distinct, and the bylines are, for lack of a better term, aligned differently. If you’re looking at this online, the menus have changed somewhat, and…

Filed under:OpinionRheuminations Tagged with:DiagnosisEmpathy

Immunology Insights for the Rheumatologist

Keri Losavio  |  October 10, 2023

The ACR journal, Arthritis & Rheumatology has introduced a new educational series, with the complement system first in focus. “This isn’t simplified immunology for trainees,” says Dr. Bucala. “It’s for everyone.”

Filed under:American College of RheumatologyResearch ReviewsResearch Rheum Tagged with:Arthritis & RheumatologycomplementImmunology

ACR Releases Update to Glucocorticoid-Induced Osteoporosis Guideline

Ruth Jessen Hickman, MD  |  October 10, 2023

The ACR recently released an update on the prevention and treatment of glucocorticoid-induced osteoporosis.1 The guideline, which includes information on the new therapies abaloparatide and romosozumab, emphasizes the importance of shared decision making by patients and clinicians, and also gives information on the importance of sequential therapy after stopping certain osteoporotic prevention therapies. Fracture Prevention…

Filed under:Clinical Criteria/GuidelinesConditionsGuidanceOsteoarthritis and Bone Disorders Tagged with:bisphosphonatesGlucocorticoid-Induced Osteoporosis

In Memoriam: The Far-Reaching Legacy of Naomi Rothfield, MD, MACR

Elizabeth Hofheinz, MPH, MEd  |  August 24, 2023

A tribute to the life and distinguished career of Naomi Rothfield, MD, MACR.

Filed under:Professional TopicsProfiles Tagged with:obituary

Fight for Change: 2 ARP Members on Why Advocacy Is Important to Them

Andre Smith & Brenda Frie, EdD, OTR/L, CHT  |  August 20, 2023

Two ARP members who currently serve on the ACR Government Affairs Committee discuss why & how they got involved in advocacy.

Filed under:Home SliderInterprofessional PerspectiveLegislation & AdvocacyProfessional Topics Tagged with:AdvocacyGovernment Affairs Committee (GAC)Interprofessional Perspectivepatient assistance

Many Medications: Understanding the Biologic Management of Psoriasis

Jason Liebowitz, MD, FACR  |  June 15, 2023

ORLANDO, FLORIDA — Given the intersection between rheumatology and dermatology for many patients with autoimmune diseases, it’s helpful to hear from specialists in both fields regarding disease management strategies.

Filed under:Biologics/DMARDsConditionsDrug UpdatesMeeting ReportsOther ACR meetings Tagged with:ACR Education ExchangeACR Education Exchange 2023BiologicsPsoriasis

Don’t Let a Good Mentor Get Away

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  June 9, 2023

“When you get a good mentor, don’t let ’em be the one that got away.” Richard Brasington Jr., MD, FACP, MACR, told me this about a decade ago when I was a rheumatology fellowship applicant and first met him. It was clear the statement was influenced by his love of fishing. Dr. Brasington’s office was…

Filed under:Career DevelopmentOpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:Dr. Hanna W. MawadDr. Mark F. GourleyDr. Richard Brasington Jr.Dr. Robert Wilkins LightfootMentorMentoringMentorship

Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

Adil Vural, MD, & Kinanah Yaseen, MD  |  May 9, 2023

Granulomatosis with polyangiitis (GPA) is a primary, necrotizing granulomatous vasculitis, involving small- to medium-sized arteries, that causes systemic disease. Almost any organ can be affected, but the most affected systems are the upper airways, lungs, kidneys, eyes and peripheral nerves. Migratory polyarthritis is reported in approximately 25% of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated…

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitiscase reportGranulomatosisgranulomatosis with polyangiitismigratory polyarthritis

  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 81
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences